For decades, millions of women dealing with irregular periods, stubborn weight gain, severe acne and fertility struggles shared a familiar, daunting diagnosis: Polycystic Ovary Syndrome (PCOS). However, that household name has officially been retired. In a landmark May 2026 announcement published in The Lancet, a global coalition of medical societies and patient advocates announced that the condition has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to reflect its true nature better.
The reason for this major upgrade is simple: the old name was fundamentally misleading. By focusing strictly on the ovaries, outdated science reduced a complex, whole-body hormonal and metabolic illness to a mere misconception about ovarian “cysts.” Unfortunately, this narrow definition led to years of subpar medical care, unnecessary stigma and painfully delayed diagnoses for countless patients. The new name acknowledges that the illness is rooted deeply in the body’s endocrine and metabolic systems, finally opening the door to the comprehensive, full-body care patients have deserved all along.
What is PMOS?
One of the most prevalent endocrine illnesses worldwide, Polyendocrine Metabolic Ovarian Syndrome (PMOS) affects about one in eight women, or more than 170 million people, according to the Endocrine Society.
The illness was formerly known as “polycystic” because ultrasound imaging frequently showed what appeared to be a “string of pearls” on the ovaries when it was first formally recognized by contemporary medicine in the middle of the 20th century. However, these tiny fluid-filled sacs are not defective cysts, according to cutting-edge biochemical research and contemporary medical imaging.
Rather, a PubMed Central publication explains that they are underdeveloped egg follicles that were not released because of underlying hormonal imbalances.
What’s happening in your body
A healthy reproductive system enables the brain and ovaries to develop and release a mature egg each month through hormonal signals. With PMOS, a hormonal traffic jam occurs in the body, which derails this communication network.
The ovaries produce slightly more of the male-type hormones (androgens), which are normally present in small amounts in all women. Ovarian egg follicles fail to mature and to ovulate because of too many androgens. Missed, irregular and excessively prolonged periods are caused by the body failing to receive the signal to produce progesterone due to blocked ovulation.
Furthermore, this hormonal imbalance is not just felt by the reproductive organs but also affects how energy is processed by all your muscle, fat and liver cells, causing metabolic roadblocks throughout your body.
Causes of PMOS
While the exact cause of PMOS is still being intensively investigated, scientists do know that it’s not due to any single component. Rather, metabolic abnormalities and genetic factors are responsible. Understanding these interconnected factors is crucial for developing effective treatment methods and managing symptoms.
Another PMC publication indicates a strong hereditary link, with those who have a family history being much more vulnerable. The way the body uses energy is also affected by underlying metabolic problems such as insulin resistance. This metabolic inefficiency and genetic susceptibility are the final causes of the disease’s development and evolution.
Insulin resistance
Insulin is the hormone that unlocks the doors to your cells so that glucose (blood sugar) can get in and provide energy. The vast majority of people who have PMOS are insulin resistant, which means that their cells do not hear the knock from insulin, the Cleveland Clinic notes.
As Dr. Justus Rabach, MD, explains, “The pancreas responds by secreting lots of extra insulin. This spurt of extra insulin in the bloodstream literally causes the ovaries to produce more harmful male hormones, further fueling the cycle. This can lead to weight gain, Type 2 diabetes, high cholesterol, infertility and long-term hormonal imbalances in females, which are more likely with time.”
Genetics and inflammation
Genetics plays an incredibly strong role in PMOS; having a mother or sister with the condition substantially increases your personal risk of developing it. This hereditary link suggests specific genetic markers predispose individuals to the disorder, making family history one of the most reliable indicators for early clinical assessment and risk management.
Also, people who have PMOS often have low-grade chronic systemic inflammation that can be seen throughout their bodies. This chronic inflammatory condition will keep pushing the overactive ovary to overproduce androgens and, at the same time, aggravate existing insulin resistance. These genetic and inflammatory factors, combined, form a vicious cycle that sustains the disease’s main features and symptoms.
Health risks and complications
PMOS is a systemic metabolic disorder and may have a wide range of potential complications.
PMOS is a long-term threat to cardiovascular and metabolic health as it causes chronic insulin resistance. The more insulin resistance goes untreated, the greater the risk of developing Type 2 diabetes and gestational diabetes, explains the American Diabetes Association.
The Centers for Disease Control and Prevention (CDC) also reports that those with this condition are at a much higher risk of developing non-alcoholic fatty liver disease, abnormal cholesterol levels, high blood pressure and metabolic syndrome. Also, when ovulation does not occur for a long time, the uterine lining may become dangerously thick, slightly raising the risk of developing uterine cancer later in life.
What to do about PMOS
If you think you might have PMOS, or if you have a diagnosis of PCOS from the past, an in-depth medical assessment is important. It is recommended that an endocrinologist or gynecologist with expertise in metabolism be consulted. They will carefully review your individual health profile to determine the way forward regarding your long-term health.
The condition is now strongly reframed as having metabolic causes, so that diagnosis does not necessarily involve the use of ultrasound to detect ovarian cysts. Rather, your clinical symptoms are closely examined and your menstrual cycle is evaluated. They may ask for extensive blood tests to establish precise fasting insulin, blood glucose and total androgen levels.
This is the biggest campaign in medical history to change a medical name, and a three-year international education and awareness campaign is ongoing. Today, your healthcare provider or insurance company may still use the acronym “PCOS” on paperwork. Still, the new terminology will be fully implemented globally in the 2028 update of the International Guideline.
When to see a doctor
Some common but recurring patterns may be concerning enough to warrant seeing a healthcare provider, especially if you’re experiencing high stress.
A medical consultation should be done if periods stop for more than 90 days or if they become much more irregular, heavier or very painful. Also, if you experience rapid, significant changes in your body that may indicate high androgen levels, consult a doctor or healthcare provider for an assessment. These symptoms can include sudden hair loss from the scalp, thick or dark hair on the face, chest, or abdomen or severe cystic acne along the jaw that does not improve with standard topical treatments.
Why was PCOS changed to PMOS?
The name was officially changed because “Polycystic Ovary Syndrome” was a very misleading title, suggesting to the patient that the root cause of the problem is abnormal ovarian cysts. The scientific community worldwide is finally recognizing that it is a complex, body-wide hormonal (“polyendocrine”) and energy-processing (“metabolic”) disorder, and is renaming it Polyendocrine Metabolic Ovarian Syndrome.
“What we now know is that there is actually no increase in abnormal cysts on the ovary, and the diverse features of the condition were often unappreciated,” explains Professor Helena Teede, an endocrinologist who spent decades researching the condition and led the global renaming process.
“It is fantastic that the new name now leads with hormones and recognizes the metabolic dimension of the condition. This shift will reframe the conversation and demand that it is taken as seriously as the long-term, complex health condition it is.”
How to treat PMOS
Since there is no specific cure for PMOS, treatment is personalized, with emphasis on regulating individual symptoms and metabolic markers. For many people, lifestyle changes alone are sufficient to improve insulin sensitivity, and healthcare providers often recommend them as natural ways to do so. Lifestyle changes, a balanced, low-glycemic-load diet and regular resistance exercise are common recommendations for naturally improving insulin sensitivity.
Medically, the condition is managed using insulin-sensitizing medications like metformin and specialized oral contraceptives to regulate the uterine lining, a PMC publication explains. Anti-androgen medications like spironolactone can help curb unwanted hair growth and acne, while targeted fertility treatments may be used if a patient is actively trying to conceive.
What happens if PMOS is left untreated?
If untreated, the long-term effects of PMOS can be serious due to the constant hormonal and metabolic disturbances. As insulin resistance worsens, individuals are at a much greater risk of Type 2 diabetes. Also, chronic inflammation and metabolic stress can lead to the occurrence of severe cardiovascular diseases.
The lack of regular ovulation also presents big problems in trying to get pregnant. In addition, this is a chronic lack of ovulation, which can lead to a buildup of the uterine lining rather than shedding as it would during normal ovulation. This steady estrogen, without the counterbalancing effect of progesterone, increases the long-term risk of uterine cancer.
Bottom line
It is time to make a big change in the way that medical science has historically viewed PCOS, so it is not surprising that this condition is now being referred to as Polyendocrine Metabolic Ovarian Syndrome (PMOS). The new name moved away from the misplaced emphasis on ovarian cysts and rightly characterized it as a body-wide hormonal and metabolic disorder, in which insulin resistance plays a significant role. The management of PMOS is a complex process that needs to be addressed comprehensively, with an emphasis on metabolic health, hormonal balance and lifestyle changes to prevent the development of complications.
Frequently Asked Questions
What foods should I avoid with PMOS?
To protect your insulin sensitivity, you should minimize your intake of highly processed foods, sugary drinks, white bread and refined carbohydrates that cause sharp spikes in your blood glucose levels.
What is the biggest indicator of PMOS?
The most common clinical indicators of PMOS are chronically irregular, skipped or completely absent menstrual periods paired with signs of elevated male-type hormones, such as excess facial hair or severe jawline acne.
Citations
Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026;0(0). doi:https://doi.org/10.1016/S0140-6736(26)00717-8
Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of the condition affecting 170 million women worldwide. Endocrine.org. Published May 12, 2026. https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
Singh S, Pal N, Shubham S, et al. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. Journal of Clinical Medicine. 2023;12(4):1454. doi:https://doi.org/10.3390/jcm12041454
Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): Current perspectives. The Application of Clinical Genetics. 2019;Volume 12(12):249-260. doi:https://doi.org/10.2147/tacg.s200341
Cleveland Clinic. Polycystic ovary syndrome (PCOS). Cleveland Clinic. Published February 15, 2023. https://my.clevelandclinic.org/health/diseases/8316-polycystic-ovary-syndrome-pcos
American Diabetes Association. Gestational Diabetes-Causes & Treatment | ADA. Diabetes.org. Published 2024. https://diabetes.org/living-with-diabetes/pregnancy/gestational-diabetes
CDC. High Blood Pressure Risk Factors. High Blood Pressure. Published December 13, 2024. https://www.cdc.gov/high-blood-pressure/risk-factors/index.html
Fraison E, Kostova E, Moran LJ, et al. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database of Systematic Reviews. 2020;(8). doi:https://doi.org/10.1002/14651858.cd005552.pub3